Suicidal behaviors are strongly linked with mood disorders, but the specific neurobiological and functional gene-expression correlates for this linkage remain elusive. We performed neuroimaging-guided RNA-sequencing in two studies to test the hypothesis that imaginglocalized gray matter volume (GMV) loss in mood disorders, harbors gene-expression changes associated with disease morbidity and related suicide mortality in an independent postmortem cohort. To do so, first, we conducted study 1 using an anatomical likelihood estimation (ALE) MRI meta-analysis including a total of 47 voxel-based morphometry (VBM) publications (i.e. 26 control>major depressive disorder (MDD) studies, and 21 control>bipolar disorder (BD) studies) in 2387 (living) participants. Study 1 meta-analysis identified a selective anterior insula cortex (AIC) GMV loss in mood disorders. We then used this results to guide study 2 postmortem tissue dissection and RNA-Sequencing of 100 independent donor brain samples with a life-time history of MDD (N=30), BD (N=37) and control (N=33). In study 2, exploratory factor-analysis identified a higher-order factor representing number of Axis-1 diagnoses (e.g. substance use disorders/psychosis/anxiety, etc.), referred to here as morbidity and suicide-completion referred to as mortality. Comparisons of case-vs-control, and factor-analysis defined higher-order-factor contrast variables revealed that the imaging-identified AIC GMV loss sub-region harbors differential gene-expression changes in high morbidity-&-mortality versus low morbidity-&mortality cohorts in immune, inflammasome, and neurodevelopmental pathways. Weighted gene co-expression network analysis further identified co-activated gene modules for psychiatric morbidity and mortality outcomes. These results provide evidence that AIC anatomical signature for mood disorders are possible correlates for gene-expression abnormalities in mood morbidity and suicide mortality. 3
INTRODUCTION
Major depressive disorder and bipolar disorder ⎯ here together referred to as mood disorders, are the third leading cause of the global disease burden (Collins et al. 2011; Murray et al. 2012) .
Mood disorders account for the majority of completed suicides (Waern et al. 2002; Marangell et al. 2006 ) and they were linked to ~47,000 suicides in the United States in 2017 alone (American Foundation for Suicide Prevention, 2019). However, the convergent neurobiological basis for mood symptoms/syndromes and suicide is unknown, limiting advances in developing novel interventions.
Neuroimaging studies have identified reduction in gray matter volume (GMV) in the anterior insular cortex (AIC) and anterior cingulate cortex (ACC) in association with diagnosis of psychiatric disorder in general (Goodkind et al. 2015) , and the regional GMV volume reductions in these AIC and ACC network have been especially implicated in mood disorder diagnoses in particular (Wise et al. 2017) . Neurobiological integrity of the right AIC is shown to (a) predict mood diagnostic severity (Hatton et al. 2012 ), (b) modulate subjective responses to distress, pain, and psychosocial adversity (Wager et al. 2013; Eisenberger 2015) , (c) regulate affective interoception (Craig 2009; Slavich et al. 2010 ), (d) associate with stress-related inflammatory markers (Khalsa et al. 2018) , and (e) predict psycho-and pharmaco-therapeutic efficacy in mood disorders (McGrath et al. 2013) . AIC-ACC functional connectivity during affective processing differentiated mood disorder suicide-attempters from non-attempters (Pan et al. 2013 ). Furthermore, abnormalities in AIC volume and synaptic abnormalities are linked to suicidal-behavior in mood disorder (Wagner et al. 2012; Mathew et al. 2013) . AIC response to stress is shown to impact hypothalamic-pituitary-adrenal (HPA) axis-driven inflammatory responses (Khalsa et al. 2013) , which may serve to exacerbate mood disorder associated psychiatric morbidity and suicidal-behavior (Oquendo et al. 2014; Wohleb et al. 2016) . Although a preponderance of evidence supports abnormal AIC integrity in psychosocial distress (Schneidman 1998; Mee et al. 2011; Wager et al. 2013 ) and mood/comorbid psychiatric symptoms, an underlying functional genetic contribution in terms of functional gene-expression changes for these abnormalities remains largely unknown.
The lack of a well-defined relationship between aberrant brain structure and function with underlying molecular changes within this brain region is an impediment to understanding pathophysiology. Moreover, evidence for shared genetic mechanisms underlying psychiatric diagnoses (Brainstorm consortium, Anttila et al. 2018 ) is not well-integrated with brain imaging correlates of psychiatric disease-morbidity and specific behaviors, in this case, suicide. In the present study, MRI meta-analysis was used to test the hypothesis that reduced AIC volume will be the most prominent neuroanatomical signature for mood disorder diagnoses. We confirmed this hypothesis with our meta-analytic findings in study 1 and then used this anatomical hallmark to guide dissection of postmortem brain tissue for analyses of molecular/gene-expression signatures that could pave the way for precision profiling of gene functions underlying mood symptoms across diagnoses in clinically-relevant brain sub-regions in study 2. This approach enabled us to further test the hypothesis that the voxel-based morphometry (VBM) imaging meta-analysis defined in study 1 will harbor postmortem gene-expression signatures for psychiatric disease morbidity and related suicide-mortality in postmortem mood disorder brains, thereby providing a neurobiological framework for characterizing convergent neural-and-gene expression signatures for behavioral brain diseases.
METHODS

PARTICIPANTS
The imaging meta-analysis provided a consolidation of the current mood disorder VBM work by quantitatively integrating published results of volumetric comparisons of interest between controls>mood disorder participants, or correlations of volumetric measures with mood disorder symptom-specific measures. In total, 47 previous VBM publications consisting of volumetric comparisons or experimental contrasts assessing GMV reductions in healthy controls > major depression from 26 independent publications (demographics in Table 1A ); and volumetric comparisons or experimental contrasts assessing GMV reductions in healthy controls > bipolar disorder from 21 independent publications (demographics in Table 1A ). Only publications with more than 20 subjects per comparison (i.e. publications with more than 10 subjects per each comparison group of major depressive disorder<controls, or bipolar disorder< controls) were selected based on the rationale that comparison group averages of less than 10 subjects per diagnostic or control group is likely underpowered in VBM studies. Together, the meta-analysis included 2387 imaging participants.
The 47 publications included in our meta-analysis, as well as relevant publications that ended up not being included based on the above-mentioned inclusion criterion, are listed in Supplementary Table 1 . While 3 of the 72 experimental contrasts included in the meta-analysis assessed suicidal behavior in relation to volumetric changes in mood disorder, suicidal phenotypes was not a specific selection criteria for study inclusion as there were very few studies in the BrainMap database that specifically assessed the relationship between suicidal phenotypes and brain volume. In study 2, RNA samples were extracted from the anatomical likelihood estimation (ALE) defined AIC sub-regional (identified in study 1) postmortem tissue of 100 donors from NIMH brain bank (postmortem technical/qualitative variables in Table 1B ).
DESIGN
Based on the principle that neural structure subserves functional control of complex behavioral repertoires (Koechlin 2016) , we localized the structural brain signature for mood disorders across samples and methods in study 1. Experiments of GMV changes associated with mood disorder diagnoses in defined stereotaxic space were included for analysis of localized GMV changes across studies in major depressive disorder, bipolar disorder, and major depressive disorder and bipolar disorder versus (vs) controls using the well-established ALE algorithm (Eickhoff et al. 2009 ). This signature guided localized anatomical-dissection of postmortem tissue for wholetranscriptome characterization of differential gene-expression and weighted gene co-expression network analysis (WGCNA).
NEUROIMAGING VBM META-ANALYSIS
For the VBM meta-analysis, results of anatomical changes reported in coordinate space using the Montreal Neurological Institute (MNI) or Talairach coordinates of 3-dimensional brain space were included from 26 publications examining major depressive disorder < controls whole-brain GMV changes; 21 publications examining bipolar disorder < controls GMV changes; and we combined the coordinates for the 26 publications examining major depressive disorder < controls and the 21 publications examining bipolar disorder < controls GMV changes for the pooled mood disorder < controls comparison. In a nutshell, the ALE approach applied here utilized in the VBM meta-analysis by modeling the spatial uncertainty associated with each reported 3-dimensional brain location of significant between-group differences in GMV changes (Eickhoff et al. 2009 ). The meta-analysis therefore performed a rigorous ALE by comparatively assessing GMV changes in (i) major depressive disorder < controls, (ii) bipolar disorder < controls, and (iii) mood disorders < controls. Here, models the spatial uncertainty associated with each reported location of significant between-group differences in GMV changes (Eickhoff et al., 2009; 2012) and performed ALE assessment of GMV changes in (i) major depressive disorder<controls, (ii) bipolar disorder<controls, and (iii) mood disorders in general (i.e., pooled across major depressive disorder and bipolar disorder) vs controls.
BRAIN DISSECTION, RNA-EXTRACTION and SEQUENCING
Brain Dissection: The NIMH Human Brain Collection Core (HBCC) provided the Postmortem samples for which informed consents are acquired according to NIH IRB guidelines. Clinical characterization, neuropathology screening, and toxicology analyses followed previous protocols (Martin et al. 2006) . The region of interest targeted for dissection was defined as portion of right AIC encompassing the identified reduced GMV in the completed meta-analysis ( Fig. 1A) by the authors. Electronic image slices of the imaging-defined GMV loss volumes are shared with the HBCC neuropathologist who used these images to guide dissection of coronal tissue slabs of each postmortem donor brain at the NIH clinical center. The dissected regional volume corresponded to the anterior portion of the insula where the caudate and putamen are approximately equal in size and tissue was dissected from this section for each brain for use in study 2 RNA-sequencing ( Fig. 1B-C ). (Andrews 2010 ). The reads were pseudo-aligned to the human reference transcriptome (GRCh38-gencode) using kallisto (Kallisto, 2019) , and gene-level abundances were obtained. The abundances were normalized using DESeq2, and transformed with variance stabilizing transformation (defined here as a transformation or normalization technique that seeks to create more homoscedasticity, and thereby having a closer to constant variance in the dataset regardless of the mean expression value). Principal Component Analysis was performed using 25% of the highest variance genes in order to look at the underlying structure of the data and to identify the largest sources of variance and thereby detect possible outliers.
RNA-Extraction
STATISTICAL ANALYSIS VBM Meta-analysis
Convergence across the findings reported in previous VBM studies was assessed using ALE, which in brief consists of first modelling the spatial uncertainty associated with each reported location for significant between-group differences (Eickhoff et al. 2009; Turkeltaub et al. 2012 ).
The ALE method therefore computes the convergence across experiments by the union of the ensuing probabilistic model relative to a null-distribution reflecting a random spatial association between the findings of different experiments ). Finally, statistical inference for a whole-brain corrected significance level of p<0.001 used the threshold-free cluster enhancement method (Smith & Nichols 2009 ). We performed ALE separately focusing on GMV changes in controls>major depressive disorder, controls>bipolar disorder, and controls>mood disorders in general (i.e., pooled across major depressive disorder and bipolar disorder).
Postmortem variable factor-analysis :
The postmortem variables included mood disorderdiagnoses; # of lifetime-Axis-I diagnostic-occurrences (e.g. Axis-I-loading of the number of comorbid disorders such as (poly)-substance use disorders, psychosis, anxiety, eating disorders, etc.); # of lifetime-Axis-III diagnoses (e.g. medical conditions such as diabetes, cancer, cardiovascular disease, etc.); manner of death (e.g. natural, suicides, homicides or accidents) and
cause of death as specified by the medical examiner reports (e.g. blunt force trauma to the chest, gunshot, motor vehicle accident, drowning, hanging, etc.); demographics (race, age at death, sex, years of education, number of children/fecundity, and marital records); technical variables (brain-weight, postmortem-index, pH, and RIN-values); and toxicology (blood alcohol/blood narcotics levels).
We applied Principal Axis Factoring using the Oblimin Rotation with Kaizer Normalization (Costello & Osborne 2005) to identify higher-order factors explaining the differences in postmortem variables and included those variables with communalities of ≥ 0.5.
Differential Gene Expression Analysis:
Just like in the imaging meta-analytic ALE, we compared AIC gene expression profiles by first conducting simple comparisons across controls>major depressive disorder, and controls>bipolar disorder.
Our factor analysis revealed that cumulatively, mood disorder-diagnoses, Axis I diagnostic-load, and manner of death together explains variability in psychiatric disease morbidity (data on any Axis-III/medical morbidity like cardiovascular disorders or cancer have not been accounted for in our analysis), and suicide mortality (i.e. mortality or completion of suicide) as a higher-order factor. The high vs low scores of this factor were determined by binning the factor scores into ≤ 0.82 for low and ≥ 0.82 for high psychiatric morbidity-&mortality scores using a split-half method of dividing the maximum score across groups by 2 (i.e.
1.64/2). Specifically, we applied a T-test by binning samples into two comparison groups for profiling gene-expression between 1) high vs low psychiatric morbidity-&-suicide-mortality across major depressed and control groups (i.e. major depressed with high scores vs major depressed and all controls with low scores); 2) high vs low psychiatric morbidity-&-suicidemortality scores across bipolar and control groups (i.e. bipolar with high scores vs bipolar and all controls with low scores); 3) high vs low psychiatric morbidity-&-suicide-mortality scores across all groups (i.e. bipolar and major depressed with high scores vs bipolar, major depressed and all controls with low scores). Differential gene-expression between samples differing in psychiatric morbidity-&-suicide-mortality status was assessed based on the negative binomial distribution for modeled gene counts using DESeq2 (Anders 7 Huber 2010). RIN-values were included in the DESeq2 design matrix as a covariate to control for its potentially confounding effects.
Our factor-analysis yielded higher-order factor representing psychiatric morbidity-&mortality including measures of suicide completion. In addition, our mood disorder samples have a substantially high incidence of completed suicides (i.e. 24 suicides vs 6 non-suicides out of 30 MDD and 28 suicides vs 9 non-suicides out of 37 bipolar samples). As such, we specifically examined the relationship between suicide completion and differential gene expression profiles by pooling non-suicide cases with controls. To do this, we applied a T-test to first compare a) gene expression difference in major depressive disorder death by suicides (n=24) reported as significantly differentially expressed. Pathways and gene-ontology (GO) terms enriched in these genes were identified using Enrichr (Chen et al. 2013; Kuleshov et al. 2016) .
Weighted Gene Co-Expression Network Analysis (WGCNA):
Scale-free co-expression networks were constructed with gene-abundances using the WGCNA package in R (Langfelder & Horvath 2008) . WGCNA provides a global perspective and allows identification of co-expressed gene-modules. It avoids relying on arbitrary-cutoffs involved in selecting differentially-expressed genes and instead identifies a group of genes that are changing in the same direction and magnitude, even if these changes are smaller in magnitude. WGCNA thereby identifies genes that are potentially co-regulated or belong to the same functional pathway, using a dynamic tree-cutting algorithm based on hierarchical clustering (i.e. minimum module size=30). To identify co-expressed gene modules of interest, we incorporated covariate information and selected those co-expressed gene modules correlating significantly with diagnostic, and suicide-linked variables. Driver genes (i.e. genes within co-expressed gene modules whose singular expression patterns are similar to the overall expression profile of the entire co-expressed modules) within these modules were used to identify pathobiological functions associated with each module.
RESULTS
Identification of a Mood Disorder Neuroanatomical Signature in Living Brains
The study 1 VBM meta-analysis (N=2387) revealed reduced GMV in the right AIC in mood disorders (p<0.0001 corrected) ( Fig 1A) consistent across both major depressive disorder and bipolar disorder, since major depressive disorder and bipolar disorder groups did not differ significantly (Fig 1A) . The localized reduced AIC neuroanatomical-signature for mood disorders was manually segmented in ITKSNAP (http://www.itksnap.org/pmwiki/pmwiki.php) (Fig 1B) and the segmented volume guided postmortem dissection of tissue used in RNA-seq characterization of gene-expression ( Fig 1C) .
Postmortem Group Differences and Factor Analysis
Using principal axis factoring of the postmortem variables in study 2, we found three factors Post-hoc multiple comparisons of the high-order factor-analytic variables yielded groupdifferences in psychiatric morbidity-&-mortality: using Bonferroni correction, psychiatric morbidity-&-mortality was highest in bipolar disorder>controls (p<0.0001, Supplementary Fig   1) ; bipolar disorder>major depressive disorder (p<0.0001, Supplementary Fig 1) , and major depressive disorder>controls (p<0.0001, Supplementary Fig 1) . Linear regression revealed that psychiatric morbidity-&-mortality negatively predicted (a) the higher-order factor termed here as RIN-scores (which is an aggregate measure of RIN-values as the variable loading highest on the factor, and negative loadings of sex and PMI which loaded weakly on this factor) at (B=-2.1, t=-3.3, p=0.001) across groups; (b) fecundity at (B=-3.17, t=-2, p=0.041, d=1.79) across groups;
and (c) age at death at (B=-8.7, t=-.27, p=0.025, d=2.1) only across major depressive disorder and bipolar disorder. These findings prescribed our subsequent analytical focus on psychiatric morbidity-&-mortality and RIN-values were included as covariates for all differential gene expression analyses. Including RIN-values as covariate was necessary especially given the negative relationship between this important measure of RNA integrity/quality (as reflected in the higher-order factor we are calling RIN-Score) and the degree of psychiatric morbidity-&mortality across the postmortem samples.
Differential-Expression Identified Enriched Postmortem Anterior Insula Gene-Expression
Signatures for Mood Disorders
Differential gene-expression analyses assessed transcriptomic profiles associated with variability between cases vs controls, between high vs low psychiatric morbidity-&-mortality, and between suicides vs non-suicides. For the case-control analysis, we compared gene expression between controls>MDD and found 351 differentially expressed genes that are mainly associated with cellular homeostatic, regulation of neurogenesis, and hormonal signaling pathways (see Supplementary Table 2 ). We further compared controls>bipolar disorder and found 23 differentially expressed genes in mainly cellular, metabolic, hormonal signaling and neurodevelopmental pathways (see Supplementary Table 3 ).
For comparison of gene expression between high vs low morbidity and mortality, we binned mood disorder associated psychiatric morbidity-&-mortality scores into ≤ 0.82 for low vs ≥ 0.82 for high scores using a split-half method of dividing the maximum score across groups by 2 (i.e. 1.64/2) and found differentially-expressed immune and inflammatory-pathways, toll-like receptor-signaling, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kbsignaling), chemokine-signaling, and cytokine-cytokine receptor interactive pathway genes (Fig   2-3, and Table 2A- (Table 2A, Fig 2A-D, Supplementary Figure 2) .
A similar differential gene-expression analysis in bipolar disorder individuals with higher psychiatric morbidity-&-mortality scores vs those with lower scores and controls was associated with 4 under-expressed innate immunity (IGHV2-70); neuroprotection, neurodevelopment and CNS-diseases including major depressive disorder (CXCL11, RP11-7461.1, & SELE) pathway genes ( Table 2B , Fig 2A-D, Supplementary Figure 3) . (Table 2-C, Fig 2A-D, Supplementary Figure 4) .
We then examined gene-expression profiles related to suicide by comparing suicide completers vs non-suicide completers with major depressive disorder and controls (i.e.
comparing gene-expression in major depressive disorder suicides vs major depressive disorder non-suicide and controls), and found 3 over-expressed WNT-signaling (FZD8); transcriptional regulation of adaptive responses to oxygen tension/hypoxia, DNA-binding transcriptional activity/co-activation (HIF3A); and dioxygenase activity (PHYHD) pathway genes (Table 2D) .
Comparing gene expression profiles for suicide completion in bipolar disorder-suicides vs nonsuicidal bipolar disorder and controls, we found 5 under-expressed innate immunity (IGHV2-5, ; and CNS-disease (SORD2P) pathway genes (Table 2E) . 1F, Fig 2D) .
IGHV2
WGCNA Identified co-regulated gene modules for Postmortem Anterior Insula Gene-Expression Signatures for Mood Disorders
WGCNA characterized the potential co-regulated gene-modules involved in mood disorder Using the 30 most highly connected (i.e. hub genes) in these two modules, the Blue module showed enrichment in genetic pathways involved in fundamental cellular signaling processes such as ATPase activity, cAMP signaling, sodium and calcium channel functions, transcriptional regulation, and neuronal development/proliferation and differentiation ( Figs. 3A-C;   Supplementary Figure 5) . The Black module showed enrichment in genetic pathways involved in innate immune functions, cellular homeostasis and metabolic regulations, dopamine DARPP32 feedback onto cAMP functions in the regulation of dopaminergic synapse, glial cell development, addiction and major depressive disorder risk (Fig. 3A-C and Fig. 4A-B;   Supplementary Figure 5 ).
DISCUSSION
Using a neuroimaging meta-analysis to refine a structurally reduced AIC region of interest in major depression and bipolar disorder, we identified a postmortem across-diagnostic mood disorder linked psychiatric morbidity-&-mortality associated gene-expression signature within this neuroimaging meta-analysis identified reduced AIC gray matter signature. Given this AIC sub-region's documented role in regulating affective and physical pain/distress, general bodily homeostatic and interoceptive salience, our convergent structural neurobiological and functional gene-expression findings of (a) a reduced right AIC gray matter signature in living mood disorder patients, coupled with (b) a preponderance of under-expressed, but also albeit to a lesser extent, over-expressed gene-expression signatures within the identified AIC-locale in mood disorder postmortem brains, identified an anatomically-precise functional gene-expression basis for mood pathologies. Of note, we found a negative relationship between measures of AIC tissue RNA integrity/RIN and mood disorder morbidity, which could have implications for our results even though we corrected for RIN as a covariate. Whether our observed negative correlations between RIN measures of AIC tissue and mood disorder morbidity and suicide mortality factors is regionally dependent needs to be assessed in future studies.
In light of the right AIC's role in sensing emotional/physical pain associated with social isolation and disconnection (Eisenberg 2015), these results provides a potential gene-regulatory windows into the neuropathological ramifications for increased mood disorder associated For instance, genetic abnormalities governing aberrant AIC-mediated social deficits (Jabbi et al. 2012 ) and severe mood disorders could attenuate reproductive prowess (Mullins et al. 2017) .
Within the identified reduced AIC signature, our differential gene-expression analyses identified predominant down-regulations in innate immune functions, inflammation pathways, and AKT-signaling related to mood-associated psychiatric morbidity and suicidal-mortality. pathogen-associated molecular patterns (Kawai & Akira 2007) and b) danger-associated molecular patterns (Klune et al. 2008; Piccinini et al. 2010) . This perspective on the multifaceted nature of brain immune signaling in relation to behavioral dysfunctions like mood disorders deserves further analysis especially in light of 1) the strong link between endogenous dangerassociated immune/inflammatory cellular functions in promoting homeostasis (Klune et al. 2008) and 2) the potential impacts of environmental stress experiences on endogenous cellular stress as well as inflammatory responses (Slavich et al. 2010) .
Existing findings of both over-expressed immune-related signals (Pandey GN 2017) , and our current imaging-guided AIC postmortem findings that clearly replicated previous results of predominantly under-expressed immune/inflammatory function (e.g. chemokine ligand 2 CCL4) and genes/pseudogenes implicated in regulatory cellular functions (e.g. a serpin peptidase inhibitor & HSPA7) in postmortem dorsolateral prefrontal cortex BA9 brains of mood disorder individuals with and without suicide completion (Pantazatos et al. 2017 ), needs to be better contextualized. For instance whether these differences in the directionality of regulatory patterns of gene-expression findings (i.e. over-expressed vs under-expressed immune expressive genes) 1 in mood disorder postmortem studies is somewhat related to methodological differences in in terms of targeted micro-RNA assays vs whole transcriptome sequencing approaches, or differences in sample sizes, sample selection criteria, or qualitative postmortem material differences between studies, needs to be examined more carefully.
While we cannot fully disentangle medication effects from diagnosis effects in our current preliminary analysis, it is worth noting that our observations suggest that diagnostic effects relating to both our suicide related and non-suicide related gene expression results are likely manifold, beyond mood disorders. This is relevant especially in light of our sample characteristics showing that suicide completion is collinear with mood disorder diagnostic severity, and that suicide completers are about 80% of the included cases. Our findings of consistently similar gene expression patterns across the various morbidity & mortality comparisons further support the thesis that suicide completion and mood disorder morbidity are likely more inter-related at the biological level than previously appreciated. Together, our current findings are consistent with data on the role of immune dysfunctions in CNS diseases (Oquendo et al. 2014; Wohleb et al. 2016; Pantazatos et al. 2017; Butovsky et al. 2018) , and inflammasome functional prediction of major depressive disorder treatment outcomes (Syed et al. 2018 ). The results further lend credence to the hypothesis that neurodevelopmental and transcription-factor genes are critical mediators of complex adaptive brain functions (Changeaux et al. 2017); especially within the context of the AIC's integration of affective and physiological feeling states (Craig 2009; Slavich et al. 2010; Kurth et al. 2010; Eisenberg 2015; Khalsa et al. 2018) 'including homeostatic maintenances in sickness and health' (Craig 2009; Khalsa et al. 2018) , that are likely not entirely independent of both pathogen-associated molecular patterns (Kawai & Akira 2007 ) and danger-associated molecular patterns (Klune et al. 2008; Piccinini et al. 2010) known to induce brain immune signaling.
At the systems level, the toll-like receptor (TLR) pathway genes found to be underexpressed here are documented to recognize conserved motifs in microorganisms (Akira 2003) and stimulation of TLRs are shown to mediate acute-immune defense and cytokine production/release (Perkins 2007) . First, it is noteworthy that the immunoglobulin heavy chain variable region 2 (IGHV2) pathway genes have shown to be more than 20-fold differentially expressed in donors with low vs. high mood disorder morbidity (Axis-I diagnostic load) and
suicide mortality in the current study. This observation of consistent under-expression of IGHV2 genes in bipolar disorder vs controls, MDD vs controls, and the pooled mood disorders vs controls suggests a possible role for the IGHV2 pathway in mood disorder morbidity and mortality, at least in the current anterior postmortem sample. Furthermore, the observed underexpression/suppression of innate immune pathway genes in higher morbidity and suicide mortality afflicted mood disorder donors point to this pathway's possible transcriptomic dysregulatory properties in depressive illness. This is especially in light of evidence that depression was the most recent episode in 21 of the 37 bipolar donors coupled with data that 26 of the 30 MDD donors have a lifetime history of recurrent depressive episodes in the current samples. To our knowledge, there are no previous reports implicating the IGHV2 pathway gene expression or genomics in mood or depression pathogenesis. However, examining the role of IGHV2 and related innate immune pathways in studies including larger mood disorder samples including more than one brain region, will help confirm their possible fundamental roles in mood illness transcriptomics.
Second, our identified under-expressed NF-κB pathway genes are implicated in controlling DNA transcription, cytokine production and cell survival (Meffert et al. 2003) , and are essential for cellular-immune response to infection, stress-related shocks (Van Amerongen et al. 2009 ), and synaptic plasticity and memory (Meffert et al. 2003; Van Amerongen et al. 2009 ).
Of interest, NF-kB pathway genes are also identified as a critical mediator of stress-impaired neurogenesis and depressive-like behavior caused by exposure to chronic stress in mice (Koo et al. 2010) . Furthermore, recent studies identified an NF-kB pathway involvement in the pathophysiology of depressive illness, especially relating to neurogenesis, synaptic transmission and plasticity (Caviedes et al. 2017) . NF-kB related mechanisms have also been shown to have antidepressive therapeutic effects in general (Wu et al. 2018 ) and in inflammatory disease comorbidity with depression-like symptoms in mice (Su et al. 2017 ).
Third, the identified under-expressed chemokine-signaling pathways govern critical spatiotemporal cell-positioning during developmental coordination and translational guidance of cell-locomotion and migration (Turner et al. 2014) . Fourth, the identified under-expressed cytokines are implicated in cell-specific innate and adaptive inflammatory host defenses, cellular-development, cell-death, angiogenesis, and maintenance of cellular homeostasis (Syed et al. 2018) . Conversely, the Wnt-β-catenin signaling pathway found to be over-expressed in major depressive disorder suicides is an evolutionarily conserved inter-cellular communication system that mediates stem cell renewal, cell-proliferation and differentiation during embryogenesis and adulthood (Meffert et al. 2003) . Taken development, addiction and major depressive disorder risks. While the regional specificity of these findings needs further analysis, the WGCNA results recapitulate the differential gene expression findings and further underscore the complex interactive gene-functions implicated in brain mediation of mood disorder morbidity and related suicidal risk tendencies.
In line with our differential gene expression and WGCNA findings of neurodevelopmental, immune, inflammatory, transcriptional, ATPase and cellular and hormonal signaling pathway alterations in mood disorder morbidity and suicides, previous gene expression studies of the postmortem prefrontal brain system of completed suicides found altered ATPase signaling in cases (Pantazatos et al. 2017) . Further studies of suicide victims with and without major depression found extensively altered limbic and hippocampal gene expression where processes linked to major depression were associated with abnormal transcription and cellular metabolic processes (Sequeira et al. 2007) . At the synaptic level, altered gene expression related to intracellular signaling in GABAergic (Sequeira et al. 2007; Sequeira et al. 2009 ) and glutamatergic transmission pathways (Sequeira et al. 2009 ) have also been reported. Gene set enrichment analysis and expression pattern exploration in postmortem brains across the lifespan in bipolar disorder has recently implicate enrichments of neurodevelopment processes in bipolar illness (Mühleisen et al. 2018) . Combining differential expression and WGCNA, a recent postmortem study identified cross-species major rearrangement of transcriptional patterns in the ERK signaling and pyramidal neuron excitability in major depressive illness, with limited overlap in males and females in both depressed humans and chronic stressed mice (Labonté et al 2017) . Taken together, substantive evidence of ATPase, cellular processes and signaling, and neurodevelopmental pathway gene expression abnormalities found in limbic and prefrontal brain regions in previous studies are in line with our current findings of AIC postmortem gene expression profiles associated with mood disorder morbidity and mortality. Future studies including multiple brain regions and sex-specific analyses will be needed to provide in-depth mechanistic understanding of the underlying transcriptional landscapes associated with diagnostic and sex-specific aspects of mood illnesses and related suicide mortality. Gandal et al. 2018) . While the cell-type specific aberrations and their relationship with differential gene expression profiles needs to be studied to better understand the molecular mechanisms underlying abnormal neuroanatomical signatures for mood symptoms, especially in-terms of diagnostic specificity between major depressive disorder and bipolar disorder, our results represent a step towards developing brain regionspecific functional gene-expression blueprints for therapeutic targeting of broad/specified molecular pathways. Furthermore, while we are not able to disentangle medication effects in our current findings, the effects of medication on gross neuroanatomical measures and geneexpression profiles also needs to be assessed in future studies. Our analysis of suicide vs nonsuicide mood disorders (excluding controls) did compare similarly medicated diagnostic cohorts and as such, our preliminary results showing similarities in gene expression profiles between suicide comparisons with and without controls suggests that our findings overall are not attributable to medication effects alone. In sum, our findings bridging convergent neuroanatomical and gene-expression signatures for measures of the degree of comorbid psychiatric symptoms in mood disorders and suicides, represents a framework for discoveries of novel biomarkers for brain diseases. are ranked by a combined score of p-value and rank based score. WGCNA identifies multiple modules of genes that are co-expressed. The module's eigengene which is representative of the expression of that module is correlated to different metadata variables to identify modules of interest. We correlated our modules to different metadata variables of postmortem sample characteristics and selected the two modules which showed significant correlation to variables of interest such as diagnoses, suicide, and the lethality of suicide methods. PMI (30.15; ) Ph (6.55; 6.25-6.92) RIN (7.37; 6.3-8.3) Abbreviations: MDD, major depressive disorder; GMV, gray matter volume; AIC, anterior insula cortex; PMI, postmortem index; Ph, measure of acidity; RIN, RNA integrity number which is a measure of RNA quality. 
